Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Wednesday, April 23, 2025

View Back issues

Shareholder Class Action

Caraco Pharmaceuticals withheld information about FDA recalls and other problems, and its share price plunged from $10.17 to $2.39 when the truth came out, shareholders say in Detroit Federal Court.           Bare Escentuals inflated its share price through false and misleading statements, shareholders say in San Francisco Federal Court.           Shareholders say MSC Software is selling itself too cheaply to Maximus Holdings, for $7.63 a share, or $360 million in Orange County Court, Calif.           Kenexa Corp. inflated its share price by withholding information about its financial condition, shareholders say in Philadelphia Federal Court.

Categories / Uncategorized

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

Loading...